Status:
UNKNOWN
Yi Jin Jing Tiger Roaring Speech Rehabilitation With Real-Time Feedback Technique for PD
Lead Sponsor:
Ruijin Hospital
Conditions:
Speech Disorders
Parkinson Disease
Eligibility:
All Genders
45-75 years
Phase:
NA
Brief Summary
Speech disorders affect more than 90% of patients with Parkinson's disease (PD). Neither of conventional drugs nor surgery can effectively improve speech function. Western speech rehabilitation is eff...
Eligibility Criteria
Inclusion
- Patients with idiopathic Parkinson's disease
- Native language is Chinese
- VHI-10 score more than 10
- informed consent
Exclusion
- Previous or concurrent medical history affecting swallowing function (laryngeal diseases such as vocal nodules, gastroesophageal reflux, and laryngeal cancer).
- History of serious psychosis
- Diagnosed by the investigators that patients with severe cardiac, liver and kidney diseases, or other serious health conditions
- Dementia (A Mini-Mental State Examination (MMSE) score of \< 24), inability to comprehend the experimental protocol or voluntarily provide informed consent
- Lack of cooperation
- Additional reasons for exclusion at the discretion of the clinical investigator
Key Trial Info
Start Date :
October 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 30 2023
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04528147
Start Date
October 1 2020
End Date
September 30 2023
Last Update
August 27 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Functional neurosurgery of Shanghai jiaotong university affiliated Ruijin hospital
Shanghai, Shanghai Municipality, China, 200025